Imagine: a single photo of your face could provide doctors with invaluable information about how you will cope with cancer treatment. Researchers at Mass General Brigham Cancer Institute have developed just such a tool based on artificial intelligence. It is capable of determining your biological age and predicting your chances of successfully completing complex therapy, whether it be chemotherapy or another aggressive intervention.
This development challenges the old notion that prognosis in oncological diseases is based solely on medical indicators, such as blood tests or biopsy results. Now, according to the developers, analyzing barely perceptible facial features – skin texture, expression lines, overall expression – can reveal hidden markers of aging and stress. These markers, which affect the body's ability to cope with therapy, may be no less important than traditional medical data.
The tool, named FaceAge, has already demonstrated in studies its ability to predict with high accuracy how successfully a patient will tolerate treatment. This opens the door to truly personalized medicine. Doctors will be able to better prepare patients for therapy, adjust dosages, or offer alternative methods, taking into account individual risks identified by AI. This is not just a new diagnostic tool, but a step towards a more informed and effective approach to cancer treatment.
In the future, such technology could become part of standard pre-operative or pre-chemotherapy assessments. This will allow doctors to make more informed decisions, and patients to better understand their risks and undergo treatment with greater confidence. Of course, this is still a research stage, but the potential to improve the quality of medical care and, consequently, the chances of recovery, is obvious. It remains to be seen how soon this technology will move from laboratories into real clinical practice.